LUGPA Announces 2026 Global Prostate Cancer Congress

September 2025

LUGPA, the only nonprofit trade association dedicated to preserving and advancing independent urology in the United States, announced the LUGPA 2026 Global Prostate Cancer Congress, to be held January 10–13, 2026 in Park City, Utah.

Aligned with LUGPA’s mission to support independent urology by demonstrating quality and value to patients, payors, legislators, vendors, and regulators, the Congress will bring together physicians, administrators, and industry partners for a multi-day educational program focused on evidence based prostate cancer care and value-based delivery models. The event is open to both members and non-members, welcoming a broad audience of urology and oncology professionals.

Highlights include:

• Care of the Whole Cancer Patient – addressing diet and the microbiome, testosterone therapy considerations, APP-directed clinics, and the caregiver/patient perspective.
• Cutting-Edge Advances in Prostate Cancer Care –comprehensive updates in prostate cancer care spanning diagnostics, genomics, localized and hormone-sensitive disease, and advanced CRPC therapies.
• Health Policy and Advocacy – with leading experts examining the impact of policy and regulation on patient care and practice management.
• Management of ADT Side Effects and Survivorship – practical approaches led by APPs, alongside updates on comprehensive patient care strategies.

“This Congress is about connection,” said E. David Crawford, MD, program chair of the event. “You'll have the chance to network with colleagues, join interactive panels on real-world cases, and enjoy everything Park City has to offer from skiing to evening receptions.”

The event also features accredited continuing medical education (CME) opportunities, networking sessions and industry-supported symposia. To learn more and register, click here.